

<!DOCTYPE html>
<html lang="en">

<head>

  <meta charset="utf-8" />
  <meta http-equiv="X-UA-Compatible" content="IE=edge" />
  <meta name="generator" content="HelpNDoc Personal Edition 7.9.1.631">
  <meta name="viewport" content="width=device-width, initial-scale=1" />
  <link rel="icon" href="favicon.ico"/>

  <title>Chapter 7 The patient who is psychotic </title>
  <meta name="description" content="" /> 
  <meta name="keywords" content="">



  

  <!-- Twitter Card data -->
  <meta name="twitter:card" content="summary">
  <meta name="twitter:title" content="Chapter 7 The patient who is psychotic ">
  <meta name="twitter:description" content="">

  <!-- Open Graph data -->
  <meta property="og:title" content="Chapter 7 The patient who is psychotic " />
  <meta property="og:type" content="article" />
  <meta property="og:description" content="" />
  <meta property="og:site_name" content="Psychiatry Clerkship" /> 

  <!-- Bootstrap core CSS -->
  <link href="vendors/bootstrap-3.4.1/css/bootstrap.min.css" rel="stylesheet"/>

  <!-- IE10 viewport hack for Surface/desktop Windows 8 bug -->
  <link href="vendors/bootstrap-3.4.1/css/ie10-viewport-bug-workaround.css" rel="stylesheet"/>

  <!-- HTML5 shim and Respond.js for IE8 support of HTML5 elements and media queries -->
  <!--[if lt IE 9]>
      <script src="vendors/html5shiv-3.7.3/html5shiv.min.js"></script>
      <script src="vendors/respond-1.4.2/respond.min.js"></script>
    <![endif]-->

  <!-- JsTree styles -->
  <link href="vendors/jstree-3.3.10/themes/default/style.min.css" rel="stylesheet"/>

  <!-- Hnd styles -->
  <link href="css/layout.min.css" rel="stylesheet" />
  <link href="css/effects.min.css" rel="stylesheet" />
  <link href="css/theme-light-blue.min.css" rel="stylesheet" />
  <link href="css/print.min.css" rel="stylesheet" media="print" />
  <style type="text/css">nav { width: 350px} @media screen and (min-width:769px) { body.md-nav-expanded div#main { margin-left: 350px} body.md-nav-expanded header { padding-left: 364px} }</style>
  <style type="text/css">.navigation #inline-toc { width: auto !important}</style>

  <!-- Content style -->
  <link href="css/hnd.content.css" rel="stylesheet" />

  



</head>

<body class="md-nav-expanded">



  <div id="skip-link">
    <a href="#main-content" class="element-invisible">Skip to main content</a>
  </div>

  <header class="headroom">
    <button class="hnd-toggle btn btn-default">
      <span class="sr-only">Toggle navigation</span>
      <span class="icon-bar"></span><span class="icon-bar"></span><span class="icon-bar"></span>        
    </button>
    <h1>Psychiatry Clerkship</h1>
    
  </header>

  <nav id="panel-left" class="md-nav-expanded">
    <!-- Nav tabs -->
    <ul class="tab-tabs nav nav-tabs" role="tablist">
      <li id="nav-close"> 
        <button class="hnd-toggle btn btn-default">
          <span class="glyphicon glyphicon-remove" aria-hidden="true"></span>
        </button>
      </li>
      
	  
        <li role="presentation" class="tab active">
            <a href="#contents" id="tab-contents" aria-controls="contents" role="tab" data-toggle="tab">
                <i class="glyphicon glyphicon-list"></i>
                Contents
            </a>
        </li>
      
        <li role="presentation" class="tab">
            <a href="#index" id="tab-index" aria-controls="index" role="tab" data-toggle="tab">
                <i class="glyphicon glyphicon-asterisk"></i>
                Index
            </a>
        </li>
      
        <li role="presentation" class="tab">
            <a href="#search" id="tab-search" aria-controls="search" role="tab" data-toggle="tab">
                <i class="glyphicon glyphicon-search"></i>
                Search
            </a>
        </li>
      
    </ul>  <!-- /Nav tabs -->

    <!-- Tab panes -->
    <div class="tab-content">
	  
      <div role="tabpanel" class="tab-pane active" id="contents">
        <div id="toc" class="tree-container unselectable"
            data-url="_toc.json"
            data-openlvl="1"
        >
            
        </div>
      </div>  <!-- /contents-->
      
      <div role="tabpanel" class="tab-pane" id="index">
        <div id="keywords" class="tree-container unselectable"
            data-url="_keywords.json"
            data-openlvl="1"
        >
            
        </div>
      </div>  <!-- /index-->
      
      <div role="tabpanel" class="tab-pane" id="search">
        <div class="search-content">
          <div class="search-input">
            <form id="search-form">
              <div class="form-group">
                <div class="input-group">
                  <input type="text" class="form-control" id="input-search" name="input-search" placeholder="Search..." />
                  <span class="input-group-btn">
                    <button class="btn btn-default" type="submit">
                      <span class="glyphicon glyphicon-search" aria-hidden="true"></span>
                    </button>
                  </span>
                </div>
              </div>
            </form>
          </div>  <!-- /search-input -->
          <div class="search-result">
            <div id="search-info"></div>
            <div class="tree-container unselectable" id="search-tree"></div>
          </div>  <!-- /search-result -->
        </div>  <!-- /search-content -->
      </div>  <!-- /search-->
      
    </div>  <!-- /Tab panes -->

  </nav>

  <div id="main">

    <article>
        <div id="topic-content" class="container-fluid" 
		  data-hnd-id="Chapter7Thepatientwhoispsychotic"
		  data-hnd-context="13"
		  data-hnd-title="Chapter 7 The patient who is psychotic "
		>
            
                <div class="navigation">
                    <ol class="breadcrumb">
                        <li><a href="ForMBBSstudents.html">For MBBS students</a></li>
                    </ol>
                    <div class="nav-arrows">
                        <div class="btn-group btn-group" role="group"><a class="btn btn-default" href="ForMBBSstudents.html" title="For MBBS students" role="button"><span class="glyphicon glyphicon-menu-up" aria-hidden="true"></span></a><a class="btn btn-default" href="Chapter5Thepatientwhoisdepressed.html" title="Chapter 5 The patient who is depressed" role="button"><span class="glyphicon glyphicon-menu-left" aria-hidden="true"></span></a><a class="btn btn-default" href="Chapter8Thepatientwhoisanxious.html" title="Chapter 8 The patient who is anxious" role="button"><span class="glyphicon glyphicon-menu-right" aria-hidden="true"></span></a></div>
                    </div>
                </div> 
            

            <a id="main-content"></a>

            

            <div class="main-content">
                
<p class="rvps19"><span class="rvts45">Chapter 7: The patient who is psychotic&nbsp;</span></p>
<p class="rvps2"><span class="rvts6"><br/></span></p>
<p class="rvps9"><a class="rvts20" href="Chapter7Thepatientwhoispsychotic.html#Pathogenesis">Pathogenesis</a><span class="rvts19">&nbsp;</span></p>
<p class="rvps9"><a class="rvts20" href="Chapter7Thepatientwhoispsychotic.html#Screening">Screening, assessment and diagnosis&nbsp;</a></p>
<p class="rvps9"><a class="rvts20" href="Chapter7Thepatientwhoispsychotic.html#Differential">Differential diagnosis&nbsp;</a></p>
<p class="rvps9"><a class="rvts20" href="Chapter7Thepatientwhoispsychotic.html#Course">Course</a></p>
<p class="rvps9"><a class="rvts20" href="Chapter7Thepatientwhoispsychotic.html#What">What is expected of a primary care clinician?</a></p>
<p class="rvps9"><a class="rvts20" href="Chapter7Thepatientwhoispsychotic.html#When">When to refer to a specialist?</a></p>
<p class="rvps9"><a class="rvts20" href="Chapter7Thepatientwhoispsychotic.html#Treatment1">Treatment: Pharmacological</a></p>
<p class="rvps9"><a class="rvts20" href="Chapter7Thepatientwhoispsychotic.html#Treatment">Treatment: Non-Pharmacological</a></p>
<p class="rvps9"><a class="rvts20" href="Chapter7Thepatientwhoispsychotic.html#Self">Self directed learning material&nbsp;</a></p>
<p class="rvps2"><span class="rvts6"><br/></span></p>
<p class="rvps2"><span class="rvts11">Primary care is often the point of first contact for patients with psychotic symptoms, and the first contact during a relapse or crisis. Identifying and treating schizophrenia and related psychotic disorders is crucial because they are linked to increased morbidity and mortality. This results from the constellation of psychiatric symptoms and co-morbid somatic illnesses, including diabetes mellitus, obesity, metabolic syndrome, hypertension, and cardiovascular and pulmonary disease.</span></p>
<p class="rvps2"><span class="rvts11"><br/></span></p>
<p class="rvps2"><span class="rvts11">These conditions are related to various factors:</span></p>
<p class="rvps2"><span class="rvts11"><br/></span></p>
<ul style="text-indent: 0px; padding: 0; margin: 0 0 0 24px; list-style-position: outside; list-style-type: disc;">
 <li class="rvps2"><span class="rvts11">disease-related (e.g., impact of symptoms on help-seeking behaviour)</span></li>
 <li class="rvps2"><span class="rvts11">lifestyle (e.g., increased rates of smoking, poor diet and inactivity)</span></li>
 <li class="rvps2"><span class="rvts11">effects of antipsychotic treatment</span></li>
 <li class="rvps2"><span class="rvts11">reduced access to primary medical care</span></li>
</ul>
<p class="rvps2"><span class="rvts11"><br/></span></p>
<p class="rvps2"><span class="rvts11">Primary care providers play a role as part of a multidisciplinary care team and often provide follow-up care once patients are no longer in regular contact with specialist. services.</span></p>
<h1 class="rvps11"><a name="Pathogenesis"></a><span class="rvts0"><span class="rvts21">Pathogenesis</span></span></h1>
<p class="rvps12"><img width="975" height="731" alt="" style="padding : 1px;" src="lib/Yu-Y-Schizophrenia-Pathogenesis-and-Clinical1.jpg"></p>
<p class="rvps29"><span class="rvts70"><br/></span></p>
<p class="rvps31"><span class="rvts73">4 Major Dopaminergic pathways in the brain and symptom / side effect association</span></p>
<p class="rvps30"><span class="rvts72"><br/></span></p>
<p class="rvps31"><img alt="" style="padding : 1px;" src="lib/Main-dopamine-pathways-in-the-brain.png"></p>
<p class="rvps31"><span class="rvts72"><br/></span></p>
<p class="rvps31"><span class="rvts73">Bottom-up and Top-down regulation</span></p>
<p class="rvps31"><span class="rvts72"><br/></span></p>
<p class="rvps31"><img alt="" style="padding : 1px;" src="lib/NewItem70.png"></p>
<ul style="text-indent: 0px; padding: 0; margin: 0 0 0 24px; list-style-position: outside; list-style-type: disc;">
 <li class="rvps30"><span class="rvts72">The 4 ascending pathways described above secrete dopamine that binds to presynaptic and postsynaptic D2 receptors and activate the neurons. These are termed as </span><span class="rvts73">bottom-up pathways</span><span class="rvts72">.</span></li>
 <li class="rvps30"><span class="rvts72">Glutamate system has seven pathways that originate in the cortex. [numbered from 1 to 8 in the figure above]</span></li>
 <ul style="text-indent: 0px; padding: 0; margin: 0 0 0 48px; list-style-position: outside; list-style-type: circle;">
  <li class="rvps30"><span class="rvts72">Most important are cortico-cortical pathways—direct pathways stimulate neighbouring neurons (4 in the figure above), whereas the indirect pathway has intervening GABA neurons; thus, it inhibits the activity of neighbouring neurons (5 in the figure above)</span></li>
  <li class="rvps30"><span class="rvts72">These neurons then project to the other brain areas forming other top-down pathways that include corticostriatal pathway (6 in figure above), corticothalamic pathway (7 in fiugure above), thalamocortical pathway (7 in figure above), corticobrainstem pathway (8 in figure above) and hippocampo–accumbens pathway (9 in Fig. 3.2.2). These</span><span class="rvts73"> top-down pathways</span><span class="rvts72"> modulate the functioning of bottom-up dopaminergic and other monoamine pathways</span></li>
  <li class="rvps30"><span class="rvts72">These top-down pathways modulate the functioning of bottom-up dopaminergic and other monoamine pathways</span></li>
 </ul>
</ul>
<p class="rvps30"><span class="rvts72"><br/></span></p>
<p class="rvps31"><span class="rvts73">Neurobiological pathology in bottom-up and top-down systems in schizophrenia spectrum disorders&nbsp;</span></p>
<p class="rvps31"><span class="rvts73"><br/></span></p>
<ul style="text-indent: 0px; padding: 0; margin: 0 0 0 24px; list-style-position: outside; list-style-type: disc;">
 <li class="rvps30"><span class="rvts72">These patients are born with faulty NMDA receptors on the GABAergic interneurons in the indirect cortico-cortical pathway (5 in the figure above). Thus, there is a dysconnectivity between glutamate and GABA neuron leading to hypoactive GABA neuron. It translates to lesser inhibition of surrounding glutaminergic neurons. In other words, we can say that they remain hyperfunctional and release excessive glutamate on the postsynaptic neurons (bottom-up neurons and other pathways), in turn, increasing their activity. it leads to increased dopamine in nucleus accumbens (dopaminergic mesolimbic pathway; 2 in Fig. 3.2.2) and produce positive symptoms, eg, hallucinations, delusions)</span></li>
 <li class="rvps30"><span class="rvts72">Same effect is noticed when the hippocampal glutamate neurons become overactive for the same reason (hypofunction of intervening GABA neurons). However, as can be seen in figure above that mesocortical pathway has intermediate GABA neuron. Its increased activity translates into a reduction of dopamine in the prefrontal cortex, thus producing negative, affective and cognitive symptoms with hypofrontality seen in these patients.</span></li>
</ul>
<p class="rvps30"><span class="rvts72"><br/></span></p>
<p class="rvps17"><span class="rvts71">Epidemiology</span></p>
<p class="rvps17"><span class="rvts69"><br/></span></p>
<ul style="text-indent: 0px; padding: 0; margin: 0 0 0 24px; list-style-position: outside; list-style-type: disc;">
 <li class="rvps17"><span class="rvts69">Prevalence: about 1%, meaning 1% of the population at a given time has schizophrenia</span></li>
 <li class="rvps17"><span class="rvts69">Incidence: about 1.5 per 10,000&nbsp;</span></li>
 <li class="rvps17"><span class="rvts69">Gender: For every 1 woman with schizophrenia there is 1.4 men with the disorder</span></li>
 <li class="rvps17"><span class="rvts69">Higher risk of suicide (20x) than the general population (240 per 100,000 compared to 12 per 100,000 annually)</span></li>
 <li class="rvps17"><span class="rvts69">Higher rates than general population of depressive and anxiety disorders, alcohol and substance use</span></li>
</ul>
<p class="rvps17"><span class="rvts71"><br/></span></p>
<p class="rvps17"><span class="rvts71">Known Risk Factors</span></p>
<p class="rvps17"><span class="rvts69"><br/></span></p>
<ul style="text-indent: 0px; padding: 0; margin: 0 0 0 24px; list-style-position: outside; list-style-type: disc;">
 <li class="rvps17"><span class="rvts69">Obstetrical complications - examples include bleeding, diabetes, prematurity, fetal growth retardation, Rhesus incompatibility, preeclampsia and congenital malformations</span></li>
 <li class="rvps17"><span class="rvts69">Late winter/early spring birth - may be related to vitamin d levels</span></li>
 <li class="rvps17"><span class="rvts69">Advanced paternal age</span></li>
 <li class="rvps17"><span class="rvts69">Strong genetic risk - this is complicated but at least 108 single nucleotide polymorphisms are associated</span></li>
</ul>
<h1 class="rvps11"><a name="Screening"></a><span class="rvts0"><span class="rvts21">Screening, assessment and diagnosis</span></span></h1>
<p class="rvps2"><span class="rvts6"><br/></span></p>
<ul style="text-indent: 0px; padding: 0; margin: 0 0 0 24px; list-style-position: outside; list-style-type: disc;">
 <li class="rvps2"><span class="rvts11">Gentle introduction</span></li>
 <ul style="text-indent: 0px; padding: 0; margin: 0 0 0 48px; list-style-position: outside; list-style-type: circle;">
  <li class="rvps2"><span class="rvts11">‘I would like to ask you some questions that might seem a little bit strange. These are questions that we ask to everyone who come to see us.’&nbsp;</span></li>
 </ul>
</ul>
<p class="rvps2"><span class="rvts11"><br/></span></p>
<ul style="text-indent: 0px; padding: 0; margin: 0 0 0 24px; list-style-position: outside; list-style-type: disc;">
 <li class="rvps2"><span class="rvts11">Quick screening questions &nbsp;</span></li>
 <ul style="text-indent: 0px; padding: 0; margin: 0 0 0 48px; list-style-position: outside; list-style-type: circle;">
  <li style="margin-left: 0px" class="rvps16"><span class="rvts11">Have you had a waking dream like experience?</span></li>
  <li style="margin-left: 0px" class="rvps16"><span class="rvts11">Have you had strange experiences?</span></li>
  <li style="margin-left: 0px" class="rvps16"><span class="rvts11">Do you hear of see things that other people can't hear or see?</span></li>
  <li style="margin-left: 0px" class="rvps16"><span class="rvts11">Do you ever feel that people are bothering you or trying to harm you?</span></li>
  <li style="margin-left: 0px" class="rvps16"><span class="rvts11">Do you feel that strangers look at you or make comments about you?</span></li>
 </ul>
</ul>
<p class="rvps2"><span class="rvts11"><br/></span></p>
<p class="rvps2"><span class="rvts11">Answering "yes" to any of these questions indicates the need for a more detailed assessment with a specialist. In addition, it is always important to obtain corroborating information from caregivers or others close to the patient.&nbsp;</span></p>
<p class="rvps2"><span class="rvts11"><br/></span></p>
<p class="rvps2"><span class="rvts11">Detailed assessment of a patient with suspected psychosis is listed </span><a class="rvts22" href="4Evaluationofpatientwithsuspecte.html">here</a><span class="rvts11">.&nbsp;</span></p>
<p class="rvps2"><span class="rvts11"><br/></span></p>
<p class="rvps20"><span class="rvts48">Case vignette</span><span class="rvts49"> </span><span class="rvts50">A 23-year-old male was brought by his family members. The family members reported that his behaviour has changed around 8 months back. Initially, the symptoms were mild but progressed gradually and he became unmanageable at home during the past 1 month. He does not sleep at all, keeps muttering as if talking to somebody whom others cannot see and is not able to take care of himself. He has a firm belief that family members want to kill him and does not eat anything at home. Out of this fear, he had called police twice in the past 3 days for help. He was an engineer working in a multinational company but now he is not able to attend to his work. Sometimes he scribbles in the notebook and writes some letters that nobody seems to understand. He stopped attending social gatherings because he feels that people talk about him and they are planning to kill him. There was no history to suggest any neurological disorder, consumption of substances of abuse or any drug ingestion. Family history was negative for any psychiatric disorder. On examination, he appeared conscious and oriented. He had poor personal hygiene and was stinking. He was poorly clad and unkempt. He was smiling without any reason and muttering. He appeared to be distracted by trivial stimuli in the surroundings. When he was asked as to why he was not eating food, he reported that the family members were actually conspiring against him so that they could snatch his property. Despite presenting contradictory evidences, he stood firm on this idea. He claimed to have a connection with the God who talks to him in three different voices. He reported that the ‘God’ directed him to do all the activities that he was doing. Based on the history and symptoms, diagnosis of schizophrenia was made and treatment was initiated.</span></p>
<h1 class="rvps11"><a name="Differential"></a><span class="rvts0"><span class="rvts21">Differential diagnosis</span></span></h1>
<p class="rvps12"><img alt="" style="padding : 1px;" src="lib/NewItem59.png"></p>
<ul style="text-indent: 0px; padding: 0; margin: 0 0 0 24px; list-style-position: outside; list-style-type: disc;">
 <li class="rvps2"><span class="rvts26">Organic conditions</span></li>
 <ul style="text-indent: 0px; padding: 0; margin: 0 0 0 48px; list-style-position: outside; list-style-type: circle;">
  <li class="rvps2"><span class="rvts11">Many medical illnesses can cause psychotic symptoms, but they generally have other symptoms and signs associated with the primary disease.</span></li>
  <li class="rvps2"><span class="rvts11">For first presentations of psychosis, a physical examination that includes a neurological examination, general medical history and review of symptoms should be conducted. Unless otherwise indicated by the history or physical examination, screening blood tests should include complete blood count, blood chemistry including electrolytes, liver function tests and a thyroid-stimulating hormone test.</span></li>
  <li class="rvps2"><span class="rvts11">For these first-time patients, a CT or MRI is recommended to rule out structural brain abnormalities.</span></li>
  <li class="rvps2"><span class="rvts11">Partial list of organic conditions and substances that can present with psychosis are shown in the figure below</span></li>
 </ul>
</ul>
<p class="rvps2"><span class="rvts11"><br/></span></p>
<p class="rvps3"><img width="525" height="712" alt="" style="padding : 1px;" src="lib/possible%20medical%20illnesses%20accoaited%20with%20psy.png"></p>
<ul style="text-indent: 0px; padding: 0; margin: 0 0 0 24px; list-style-position: outside; list-style-type: disc;">
 <li class="rvps2"><span class="rvts26">Specific psychotic disorder</span></li>
 <ul style="text-indent: 0px; padding: 0; margin: 0 0 0 48px; list-style-position: outside; list-style-type: circle;">
  <li class="rvps2"><span class="rvts26">Schizophrenia</span></li>
  <ul style="text-indent: 0px; padding: 0; margin: 0 0 0 48px; list-style-position: outside; list-style-type: square;">
   <li class="rvps2"><span class="rvts11">Core symptoms - Any 2 out of 5&nbsp;</span></li>
   <ul style="text-indent: 0px; padding: 0; margin: 0 0 0 48px; list-style-position: outside; list-style-type: disc;">
    <li class="rvps2"><span class="rvts11">Delusion</span></li>
    <li class="rvps2"><span class="rvts11">Hallucination</span></li>
    <li class="rvps2"><span class="rvts11">Disorganized speech</span></li>
    <li class="rvps2"><span class="rvts11">Disorganized behaviour</span></li>
    <li class="rvps2"><span class="rvts11">Negative symptoms&nbsp;</span></li>
    <li class="rvps2"><span class="rvts11">for at-least 1 month</span></li>
    <li class="rvps2"><span class="rvts11">at-least 1 symptom from 1-3 &nbsp;</span></li>
   </ul>
   <li class="rvps2"><span class="rvts11">Duration - total illness duration more than 6 months</span></li>
   <li class="rvps2"><span class="rvts30">Distress - Impaired function or needing hospitalization</span></li>
   <li class="rvps2"><span class="rvts11">Differentials&nbsp;</span></li>
   <ul style="text-indent: 0px; padding: 0; margin: 0 0 0 48px; list-style-position: outside; list-style-type: disc;">
    <li class="rvps2"><span class="rvts11">Substance&nbsp;</span></li>
    <li class="rvps2"><span class="rvts11">Organic condition</span></li>
    <li class="rvps2"><span class="rvts11">Other psychiatric conditions&nbsp;</span></li>
   </ul>
  </ul>
  <li class="rvps2"><span class="rvts26">Brief psychotic disorder</span></li>
  <ul style="text-indent: 0px; padding: 0; margin: 0 0 0 48px; list-style-position: outside; list-style-type: square;">
   <li class="rvps2"><span class="rvts11">Brief psychotic disorder is characterized by psychotic symptoms lasting at least one day but less than one month.</span></li>
  </ul>
  <li class="rvps2"><span class="rvts26">Schizophreniform disorder</span></li>
  <ul style="text-indent: 0px; padding: 0; margin: 0 0 0 48px; list-style-position: outside; list-style-type: square;">
   <li class="rvps2"><span class="rvts11">Schizophreniform disorder is characterized by symptoms of schizophrenia that last at least one month but less than six months.</span></li>
  </ul>
  <li class="rvps2"><span class="rvts26">Delusional disorder</span></li>
  <ul style="text-indent: 0px; padding: 0; margin: 0 0 0 48px; list-style-position: outside; list-style-type: square;">
   <li class="rvps2"><span class="rvts11">Delusional disorder is characterized by non-bizarre delusions and the absence of other characteristic symptoms of schizophrenia (e.g., hallucinations, negative symptoms, disorganized speech or behaviour).</span></li>
  </ul>
  <li class="rvps2"><span class="rvts26">Schizoaffective disorder</span></li>
  <ul style="text-indent: 0px; padding: 0; margin: 0 0 0 48px; list-style-position: outside; list-style-type: square;">
   <li class="rvps2"><span class="rvts11">Schizoaffective disorder is characterized by a mood episode that is concurrent with psychotic symptoms of schizophrenia, where the mood symptoms are present for a substantial portion of the total duration of the disturbance, and psychotic symptoms must also be present for at least two weeks in the absence of prominent mood symptoms.</span></li>
  </ul>
 </ul>
 <li class="rvps2"><span class="rvts11">Other psychiatric conditions that can present with symptoms of psychosis&nbsp;</span></li>
 <ul style="text-indent: 0px; padding: 0; margin: 0 0 0 48px; list-style-position: outside; list-style-type: circle;">
  <li class="rvps2"><span class="rvts26">Mood disorder with psychotic features</span><span class="rvts11"> (depression or mania). Mood disorder with psychotic features can be differentiated from schizophrenia by the exclusive appearance of psychotic symptoms during periods of mood disturbance.</span></li>
  <li class="rvps2"><span class="rvts11">Psychotic like experiences in PTSD</span></li>
  <li class="rvps2"><span class="rvts11">Micro-psychotic episodes in Borderline personality disorder&nbsp;</span></li>
  <li class="rvps2"><span class="rvts11">Schizotypal personality disorder &nbsp;</span></li>
 </ul>
 <li class="rvps2"><span class="rvts11">Catatonia specifier</span></li>
 <li class="rvps2"><span class="rvts11">Schizophrenia subtypes</span></li>
</ul>
<p class="rvps2"><span class="rvts11"><br/></span></p>
<p class="rvps8"><a name="Course"></a><span class="rvts57">Course</span></p>
<p class="rvps12"><img width="875" height="383" alt="" style="padding : 1px;" src="lib/NewItem61.png"></p>
<p class="rvps3"><span class="rvts68"><br/></span></p>
<p class="rvps12"><img width="469" height="406" alt="" style="padding : 1px;" src="lib/NewItem60.png"></p>
<p class="rvps3"><span class="rvts68"><br/></span></p>
<p class="rvps12"><img width="851" height="455" alt="" style="padding : 1px;" src="lib/NewItem62.png"></p>
<h1 class="rvps11"><a name="What"></a><span class="rvts0"><span class="rvts21">What is expected of a primary care clinician?</span></span></h1>
<ul style="text-indent: 0px; padding: 0; margin: 0 0 0 24px; list-style-position: outside; list-style-type: disc;">
 <li class="rvps2"><span class="rvts11">Diagnose and carry out initial screening for underlying medical illnesses.</span></li>
 <li class="rvps2"><span class="rvts11">Assess suicide risk.</span></li>
 <li class="rvps2"><span class="rvts11">Monitor treatment response and symptom severity.</span></li>
 <li class="rvps2"><span class="rvts11">Monitor extrapyramidal symptoms.</span></li>
 <li class="rvps2"><span class="rvts11">Monitor metabolic and cardiovascular risk factors for all patients prescribed antipsychotic medication, particularly SGAs, regardless of which physician is prescribing antipsychotic medications.</span></li>
 <li class="rvps2"><span class="rvts11">Manage co-morbid somatic illnesses.</span></li>
 <li class="rvps2"><span class="rvts11">Refer when necessary.</span></li>
</ul>
<h1 class="rvps11"><a name="When"></a><span class="rvts0"><span class="rvts21">When to refer to a specialist?&nbsp;</span></span></h1>
<ul style="text-indent: 0px; padding: 0; margin: 0 0 0 24px; list-style-position: outside; list-style-type: disc;">
 <li class="rvps2"><span class="rvts11">First presentation of psychotic symptoms</span></li>
 <li class="rvps2"><span class="rvts11">Diagnostic clarification and treatment</span></li>
 <li class="rvps2"><span class="rvts11">Severe presentation (safety risks to self or others, serious functional impairment, co-morbid medical or substance use issues)</span></li>
 <li class="rvps2"><span class="rvts11">Refractory to standard treatment (two or more medication trials)</span></li>
 <li class="rvps2"><span class="rvts11">Acute decompensation</span></li>
 <li class="rvps2"><span class="rvts11">Persistent negative symptoms&nbsp;</span></li>
 <li class="rvps2"><span class="rvts11">When considering the use of clozapine or ECT</span></li>
</ul>
<h1 class="rvps11"><a name="Treatment1"></a><span class="rvts0"><span class="rvts21">Treatment: Pharmacological&nbsp;</span></span></h1>
<p class="rvps2"><span class="rvts26"><br/></span></p>
<p class="rvps2"><span class="rvts26">Acute treatment&nbsp;</span></p>
<p class="rvps2"><span class="rvts11"><br/></span></p>
<p class="rvps2"><span class="rvts11">The goals for acute treatment of a patient presenting with psychosis include:</span></p>
<p class="rvps2"><span class="rvts11"><br/></span></p>
<ul style="text-indent: 0px; padding: 0; margin: 0 0 0 24px; list-style-position: outside; list-style-type: disc;">
 <li class="rvps2"><span class="rvts11">diagnostic assessment</span></li>
 <li class="rvps2"><span class="rvts11">assessing the potential for danger to self or others</span></li>
 <li class="rvps2"><span class="rvts11">engaging the patient and caregivers in the treatment process, including a discussion about risks and benefits of treatment</span></li>
 <li class="rvps2"><span class="rvts11">initiating pharmacologic treatment as soon as possible</span></li>
</ul>
<p class="rvps2"><span class="rvts11"><br/></span></p>
<p class="rvps2"><span class="rvts11">Usually there is not one definite choice of medication for any given patient, since there is much individual variability in efficacy and side-effects. The choice is based primarily on individual profiles of efficacy and tolerability. Following factors are considered when choosing an antipsychotic medication:</span></p>
<p class="rvps2"><span class="rvts11"><br/></span></p>
<ul style="text-indent: 0px; padding: 0; margin: 0 0 0 24px; list-style-position: outside; list-style-type: disc;">
 <li class="rvps2"><span class="rvts11">There is emerging evidence that SGAs and FGAs may be equally effective in treating schizophrenia or schizoaffective disorder.</span></li>
 <li class="rvps2"><span class="rvts11">Second-generation antipsychotic medications (SGAs) are preferred as first-choice treatments, especially for previously unmedicated patients who are particularly sensitive to acute extrapyramidal and sedative side-effects caused by antipsychotics.</span></li>
 <li class="rvps2"><span class="rvts11">The SGAs, including olanzapine, risperidone, quetiapine and aripiprazole, offer improved tolerability, particularly with regard to extrapyramidal symptoms, compared with first-generation antipsychotics (FGAs).&nbsp;</span></li>
 <li class="rvps2"><span class="rvts11">All antipsychotics carry a risk of extrapyramidal symptoms and tardive dyskinesia, although the risk appears to be higher with FGAs compared to SGAs. Of the SGAs, the risk of extrapyramidal symptoms seems to be highest with risperidone.</span></li>
 <li class="rvps2"><span class="rvts11">All antipsychotics carry a risk of weight gain and metabolic abnormalities, although the risk appears to be higher with SGAs, particularly olanzapine, quetiapine and clozapine.</span></li>
 <li class="rvps2"><span class="rvts11">Risperidone is the SGA most commonly associated with elevated prolactin levels and subsequent amenorrhoea and sexual dysfunction.</span></li>
 <li class="rvps2"><span class="rvts11">Clozapine appears to be a unique SGA that exhibits superiority in treating treatment-resistant patients with schizophrenia or schizoaffective disorder (patients who have not benefited from previous trials of two antipsychotics). Clozapine treatment carries a risk of agranulocytosis, which requires regular monitoring of white blood cell and neutrophil counts (weekly for the first six months, biweekly for the next six months, monthly thereafter). The risk is approximately 0.5 to two per cent, and appears to be greatest in the early stages of treatment initiation.</span></li>
 <li class="rvps2"><span class="rvts11">For schizoaffective disorder, treatment typically combines an antipsychotic with a medication aimed at treating the mood disturbance.</span></li>
</ul>
<p class="rvps2"><span class="rvts11"><br/></span></p>
<p class="rvps3"><span class="rvts26">Table: Commonly used antipsychotics</span></p>
<div class="rvps3">
<table width="100%" border="1" cellpadding="1" cellspacing="2" style="border-color: #000000; border-style: solid; border-spacing: 2px; margin: 0px auto;">
 <tr valign="top">
  <td style="border-color: #000000; border-style: solid; padding: 1px;">
   <p class="rvps2"><span class="rvts11">Name</span></p>
  </td>
  <td style="border-color: #000000; border-style: solid; padding: 1px;">
   <p class="rvps2"><span class="rvts11">Preparation</span></p>
  </td>
  <td style="border-color: #000000; border-style: solid; padding: 1px;">
   <p class="rvps2"><span class="rvts11">Dose-Range</span></p>
  </td>
  <td style="border-color: #000000; border-style: solid; padding: 1px;">
   <p class="rvps2"><span class="rvts11">Major Adverse Effects</span></p>
  </td>
 </tr>
 <tr valign="top">
  <td style="border-color: #000000; border-style: solid; padding: 1px;">
   <p class="rvps2"><span class="rvts26">First generation&nbsp;</span></p>
  </td>
  <td style="border-color: #000000; border-style: solid; padding: 1px;">
   <p class="rvps2"><span class="rvts11"><br/></span></p>
  </td>
  <td style="border-color: #000000; border-style: solid; padding: 1px;">
   <p class="rvps2"><span class="rvts11"><br/></span></p>
  </td>
  <td style="border-color: #000000; border-style: solid; padding: 1px;">
   <p class="rvps2"><span class="rvts11"><br/></span></p>
  </td>
 </tr>
 <tr valign="top">
  <td style="border-color: #000000; border-style: solid; padding: 1px;">
   <p class="rvps2"><span class="rvts11">Haloperidol&nbsp;</span></p>
  </td>
  <td style="border-color: #000000; border-style: solid; padding: 1px;">
   <p class="rvps2"><span class="rvts11">Oral&nbsp;</span></p>
  </td>
  <td style="border-color: #000000; border-style: solid; padding: 1px;">
   <p class="rvps2"><span class="rvts11">1-20mg/day</span></p>
  </td>
  <td style="border-color: #000000; border-style: solid; padding: 1px;">
   <p class="rvps2"><span class="rvts11">EPS, NMS</span></p>
  </td>
 </tr>
 <tr valign="top">
  <td style="border-color: #000000; border-style: solid; padding: 1px;">
   <p class="rvps2"><span class="rvts11">Trifluoperazine&nbsp;</span></p>
  </td>
  <td style="border-color: #000000; border-style: solid; padding: 1px;">
   <p class="rvps2"><span class="rvts11">Oral&nbsp;</span></p>
  </td>
  <td style="border-color: #000000; border-style: solid; padding: 1px;">
   <p class="rvps2"><span class="rvts11">5-30mg/day</span></p>
  </td>
  <td style="border-color: #000000; border-style: solid; padding: 1px;">
   <p class="rvps2"><span class="rvts11">EPS</span></p>
  </td>
 </tr>
 <tr valign="top">
  <td style="border-color: #000000; border-style: solid; padding: 1px;">
   <p class="rvps2"><span class="rvts11">Fluphenazine&nbsp;</span></p>
  </td>
  <td style="border-color: #000000; border-style: solid; padding: 1px;">
   <p class="rvps2"><span class="rvts11">Long-acting</span></p>
  </td>
  <td style="border-color: #000000; border-style: solid; padding: 1px;">
   <p class="rvps2"><span class="rvts11">25mg per 3 weeks upto 100mg every 2 weeks&nbsp;</span></p>
  </td>
  <td style="border-color: #000000; border-style: solid; padding: 1px;">
   <p class="rvps2"><span class="rvts11">Photosensitivity</span></p>
  </td>
 </tr>
 <tr valign="top">
  <td style="border-color: #000000; border-style: solid; padding: 1px;">
   <p class="rvps2"><span class="rvts26">Second generation</span></p>
  </td>
  <td style="border-color: #000000; border-style: solid; padding: 1px;">
   <p class="rvps2"><span class="rvts11"><br/></span></p>
  </td>
  <td style="border-color: #000000; border-style: solid; padding: 1px;">
   <p class="rvps2"><span class="rvts11"><br/></span></p>
  </td>
  <td style="border-color: #000000; border-style: solid; padding: 1px;">
   <p class="rvps2"><span class="rvts11"><br/></span></p>
  </td>
 </tr>
 <tr valign="top">
  <td style="border-color: #000000; border-style: solid; padding: 1px;">
   <p class="rvps2"><span class="rvts11">Olanzapine&nbsp;</span></p>
  </td>
  <td style="border-color: #000000; border-style: solid; padding: 1px;">
   <p class="rvps2"><span class="rvts11">Oral</span></p>
  </td>
  <td style="border-color: #000000; border-style: solid; padding: 1px;">
   <p class="rvps2"><span class="rvts11">5-20mg/day&nbsp;</span></p>
  </td>
  <td style="border-color: #000000; border-style: solid; padding: 1px;">
   <p class="rvps2"><span class="rvts11">Metabolic syndrome, sedation, weight gain, EPS&nbsp;</span></p>
  </td>
 </tr>
 <tr valign="top">
  <td style="border-color: #000000; border-style: solid; padding: 1px;">
   <p class="rvps2"><span class="rvts11">Risperidone&nbsp;</span></p>
  </td>
  <td style="border-color: #000000; border-style: solid; padding: 1px;">
   <p class="rvps2"><span class="rvts11">Oral</span></p>
  </td>
  <td style="border-color: #000000; border-style: solid; padding: 1px;">
   <p class="rvps2"><span class="rvts11">2-12mg/day&nbsp;</span></p>
  </td>
  <td style="border-color: #000000; border-style: solid; padding: 1px;">
   <p class="rvps2"><span class="rvts11">Weight gain, EPS</span></p>
  </td>
 </tr>
 <tr valign="top">
  <td style="border-color: #000000; border-style: solid; padding: 1px;">
   <p class="rvps2"><span class="rvts11">Quetiapine&nbsp;</span></p>
  </td>
  <td style="border-color: #000000; border-style: solid; padding: 1px;">
   <p class="rvps2"><span class="rvts11">Oral&nbsp;</span></p>
  </td>
  <td style="border-color: #000000; border-style: solid; padding: 1px;">
   <p class="rvps2"><span class="rvts11">150mg-800mg/day</span></p>
  </td>
  <td style="border-color: #000000; border-style: solid; padding: 1px;">
   <p class="rvps2"><span class="rvts11">Sedation, Weight gain</span></p>
  </td>
 </tr>
 <tr valign="top">
  <td style="border-color: #000000; border-style: solid; padding: 1px;">
   <p class="rvps2"><span class="rvts11">Aripiprazole&nbsp;</span></p>
  </td>
  <td style="border-color: #000000; border-style: solid; padding: 1px;">
   <p class="rvps2"><span class="rvts11">Oral&nbsp;</span></p>
  </td>
  <td style="border-color: #000000; border-style: solid; padding: 1px;">
   <p class="rvps2"><span class="rvts11">10-30mg/day&nbsp;</span></p>
  </td>
  <td style="border-color: #000000; border-style: solid; padding: 1px;">
   <p class="rvps2"><span class="rvts11"><br/></span></p>
  </td>
 </tr>
 <tr valign="top">
  <td style="border-color: #000000; border-style: solid; padding: 1px;">
   <p class="rvps2"><span class="rvts11">Amisulpride</span></p>
  </td>
  <td style="border-color: #000000; border-style: solid; padding: 1px;">
   <p class="rvps2"><span class="rvts11">Oral&nbsp;</span></p>
  </td>
  <td style="border-color: #000000; border-style: solid; padding: 1px;">
   <p class="rvps2"><span class="rvts11">400-800mg/day&nbsp;</span></p>
  </td>
  <td style="border-color: #000000; border-style: solid; padding: 1px;">
   <p class="rvps2"><span class="rvts11">Hyperprolactinemia</span></p>
  </td>
 </tr>
</table>
</div>
<p class="rvps3"><span class="rvts11"><br/></span></p>
<div class="rvps2">
<table width="100%" border="0" cellpadding="1" cellspacing="2" style="border-width: 0px; border-spacing: 2px;">
 <tr valign="top">
  <td width="27" style="padding: 1px;">
   <p class="rvps2"><span class="rvts63">⚠️</span></p>
  </td>
  <td width="932" valign="middle" style="padding: 1px;">
   <p class="rvps2"><span class="rvts11">Monitor metabolic and cardiovascular risk factors for all patients prescribed antipsychotic medication.</span></p>
  </td>
 </tr>
</table>
</div>
<p class="rvps2"><span class="rvts11"><br/></span></p>
<p class="rvps2"><span class="rvts26">Maintenance treatment</span></p>
<p class="rvps2"><span class="rvts11"><br/></span></p>
<p class="rvps2"><span class="rvts11">The goals for maintenance treatment of schizophrenia or schizoaffective disorder are:</span></p>
<p class="rvps2"><span class="rvts11"><br/></span></p>
<ul style="text-indent: 0px; padding: 0; margin: 0 0 0 24px; list-style-position: outside; list-style-type: disc;">
 <li class="rvps2"><span class="rvts11">improvement in functional recovery</span></li>
 <li class="rvps2"><span class="rvts11">prevention of relapse and recurrence</span></li>
 <li class="rvps2"><span class="rvts11">treatment adherence</span></li>
</ul>
<p class="rvps2"><span class="rvts11"><br/></span></p>
<p class="rvps3"><img alt="" style="padding : 1px;" src="lib/NewItem71.png"></p>
<p class="rvps3"><span class="rvts11">Role of medications in Schizophrenia spectrum disorders&nbsp;</span></p>
<p class="rvps2"><span class="rvts11"><br/></span></p>
<p class="rvps2"><span class="rvts11">Following treatment of a first episode of psychosis, with symptom remission and functional recovery while on medications for approximately two years, consider a trial of no medications. However, which patients can safely and permanently discontinue antipsychotic medications cannot be predicted. Medication should be withdrawn gradually over six to 12 months, and symptoms and functioning monitored closely.&nbsp;</span></p>
<p class="rvps2"><span class="rvts11"><br/></span></p>
<p class="rvps2"><span class="rvts11">Relapse rates are estimated at 60 per cent or higher over two years. Of patients with a first episode of psychosis, 80 per cent are at risk of a second episode within the first three to five years, with recovery from subsequent episodes being slower and often less complete. Following a second psychotic episode, it becomes highly unlikely that patients will remain relapse-free if they go off antipsychotic medication.</span></p>
<p class="rvps2"><span class="rvts11"><br/></span></p>
<p class="rvps2"><span class="rvts26">Non-compliance&nbsp;</span></p>
<p class="rvps2"><span class="rvts11">Non-compliance with long-term antipsychotic treatment is very high. An estimated 40 to 50 percent of patients become non-compliant within 1 or 2 years. Long-acting injectable antipsychotics were developed to help improve adherence, particularly in patients likely to discontinue daily oral medications.</span></p>
<p class="rvps2"><span class="rvts11"><br/></span></p>
<p class="rvps2"><span class="rvts26">Other somatic treatments</span></p>
<p class="rvps2"><span class="rvts11">1. ECT: Indication (Schizophrenia with acute exacerbation or catatonic subtype). ECT is about as effective as antipsychotic medications and more effective than psychotherapy. Antipsychotic medications should be administered during and after ECT treatment.</span></p>
<p class="rvps2"><span class="rvts11">2. TMS (Transcranial Magnetic Stimulation)</span></p>
<p class="rvps2"><span class="rvts11">3. TDCS (Transcranial direct current stimulation)</span></p>
<h1 class="rvps11"><a name="Treatment"></a><span class="rvts0"><span class="rvts21">Treatment: Non-Pharmacological&nbsp;</span></span></h1>
<p class="rvps2"><span class="rvts58"><br/></span></p>
<p class="rvps2"><span class="rvts58">Psychotherapy and psychosocial interventions:</span><span class="rvts50"> are an important component of treatment for patients with schizophrenia and schizoaffective disorder. They are typically administered through local speciality psychiatric services. These approaches include:</span></p>
<p class="rvps2"><span class="rvts50"><br/></span></p>
<ul style="text-indent: 0px; padding: 0; margin: 0 0 0 24px; list-style-position: outside; list-style-type: disc;">
 <li class="rvps2"><span class="rvts50"> Cognitive-behavioural therapy (CBT): Particularly useful for treatment-resistant patients with persistent positive or negative symptoms.</span></li>
 <li class="rvps2"><span class="rvts50"> Family interventions: Include family psychoeducation, multiple-family groups (particularly early in the course of the illness), and evaluating and addressing caregiver burden.</span></li>
 <li class="rvps2"><span class="rvts50"> Employment and academic interventions: Include supported employment and academic accommodations through student services at secondary and post-secondary institutions</span></li>
 <li class="rvps2"><span class="rvts50"> Social skills and life skills training: Teach independent living skills to help people with schizophrenia function in their communities.</span></li>
</ul>
<p class="rvps2"><span class="rvts50"><br/></span></p>
<p class="rvps2"><span class="rvts58">Psychoeducation: </span><span class="rvts50">helps people with schizophrenia to understand and cope with their illness. It is linked to reduced relapse and readmission rates, improved medication adherence and better quality of life. It should be an ongoing process with patients and their families. Psychoeducation can deliver the following simple messages to improve medication adherence:</span></p>
<p class="rvps2"><span class="rvts50"><br/></span></p>
<ul style="text-indent: 0px; padding: 0; margin: 0 0 0 24px; list-style-position: outside; list-style-type: disc;">
 <li class="rvps2"><span class="rvts50">Antipsychotics can take a couple of weeks to start working.</span></li>
 <li class="rvps2"><span class="rvts50">Take the medications every day.</span></li>
 <li class="rvps2"><span class="rvts50">Side-effects are usually mild and improve over time.</span></li>
 <li class="rvps2"><span class="rvts50">Continue your medications, even after you feel better, or your symptoms may return.</span></li>
 <li class="rvps2"><span class="rvts50">Do not stop antipsychotic medication before checking with your doctor.</span></li>
 <li class="rvps2"><span class="rvts50">Alcohol and recreational drugs can affect how well the medication works.</span></li>
</ul>
<p class="rvps2"><span class="rvts50"><br/></span></p>
<p class="rvps2"><span class="rvts50">Take a self-management approach with patients:</span></p>
<p class="rvps2"><span class="rvts50"><br/></span></p>
<ul style="text-indent: 0px; padding: 0; margin: 0 0 0 24px; list-style-position: outside; list-style-type: disc;">
 <li class="rvps2"><span class="rvts50">Always include patient education (e.g., patient information handouts)</span></li>
 <li class="rvps2"><span class="rvts50">Involve patients, and their families when appropriate, in the management of their own illness by actively collaborating with them in the diagnosis and treatment planning.</span></li>
</ul>
<h1 class="rvps14"><a name="Self"></a><span class="rvts0"><span class="rvts21">Self directed learning material for psychosis&nbsp;</span></span></h1>
<p class="rvps2"><span class="rvts11"><br/></span></p>
<p class="rvps2"><span class="rvts11">1. The causes of psychosis&nbsp;</span></p>
<p class="rvps2"><span class="rvts11"><br/></span></p>
<p class="rvps2"><span class="rvts11"><iframe width="320" height="200" src="https://www.youtube.com/embed/e3EnPQDpGpg" frameborder="0" allow="accelerometer; autoplay; clipboard-write; encrypted-media; gyroscope; picture-in-picture" allowfullscreen=""></iframe></span></p>
<p class="rvps2"><span class="rvts11"><br/></span></p>
<p class="rvps2"><span class="rvts11">2. Psychosis and cannabis&nbsp;</span></p>
<p class="rvps2"><span class="rvts11"><br/></span></p>
<p class="rvps2"><span class="rvts11"><iframe width="320" height="200" src="https://www.youtube.com/embed/K6ISPvlVNU4" frameborder="0" allow="accelerometer; autoplay; clipboard-write; encrypted-media; gyroscope; picture-in-picture" allowfullscreen=""></iframe></span></p>
<p class="rvps2"><span class="rvts11"><br/></span></p>
<p class="rvps2"><span class="rvts11">3. Psychosis and genetics</span></p>
<p class="rvps2"><span class="rvts11"><br/></span></p>
<p class="rvps2"><span class="rvts11"><iframe width="320" height="200" src="https://www.youtube.com/embed/KxlvNGEsPuQ" frameborder="0" allow="accelerometer; autoplay; clipboard-write; encrypted-media; gyroscope; picture-in-picture" allowfullscreen=""></iframe></span></p>
<p class="rvps2"><span class="rvts11"><br/></span></p>
<p class="rvps2"><span class="rvts11">4. Psychosis and stress&nbsp;</span></p>
<p class="rvps2"><span class="rvts11"><br/></span></p>
<p class="rvps2"><span class="rvts11"><iframe width="320" height="200" src="https://www.youtube.com/embed/VYzweIoENHY" frameborder="0" allow="accelerometer; autoplay; clipboard-write; encrypted-media; gyroscope; picture-in-picture" allowfullscreen=""></iframe></span></p>
<p class="rvps2"><span class="rvts11"><br/></span></p>
<p class="rvps2"><span class="rvts11">5. Psychiatric interview for teaching psychosis&nbsp;</span></p>
<p class="rvps2"><span class="rvts11"><br/></span></p>
<p class="rvps2"><span class="rvts11"><iframe width="320" height="200" src="https://www.youtube.com/embed/ZB28gfSmz1Y" frameborder="0" allow="accelerometer; autoplay; clipboard-write; encrypted-media; gyroscope; picture-in-picture" allowfullscreen=""></iframe></span></p>
<p class="rvps2"><span class="rvts11"><br/></span></p>
<p class="rvps2"><span class="rvts11">6. ADMSEP module of psychosis - </span><a class="rvts22" href="https://www.admsep.org/csi-emodules.php?c=psychotic&v=y" target="_blank">link</a><span class="rvts11">&nbsp;</span></p>
<h1 class="rvps11"><span class="rvts0"><span class="rvts21">Bib</span></span><a name="Bibliography"></a><span class="rvts0"><span class="rvts21">liography&nbsp;</span></span></h1>
<p class="rvps2"><span class="rvts11">1. Portico network - Psychiatry in Primary Care Toolkit</span></p>
<p class="rvps2"><span class="rvts11">2. Black Book - University of Calgary</span></p>
<p class="rvps2"><span class="rvts11">4. Synopsis of Psychiatry 11e.</span></p>
<p class="rvps2"><span class="rvts11">5. Gulati, Gautam; Cullen, Walter; Kelly, Brendan. Psychiatry Algorithms for Primary Care. Wiley. Kindle Edition.&nbsp;</span></p>
<p class="rvps2"><span class="rvts11">6. thecalgaryguide.com</span></p>
<p class="rvps2"><span class="rvts11">7. ADMSEP modules&nbsp;</span></p>
<p class="rvps2"><span class="rvts11">8. University of Nottinhgam teaching videos</span></p>
<p class="rvps2"><span class="rvts11">9. https://www.researchgate.net/publication/283480867_The_concept_of_schizophrenia</span></p>
<p class="rvps2"><span class="rvts11">10. https://institute.progress.im/en/content/course-natural-history-and-prognosis-2</span></p>
<p class="rvps2"><span class="rvts11">11. GUPTA, RAVI. Psychiatry for Beginners - E-Book. Elsevier Health Sciences. Kindle Edition. </span><span class="rvts6"></span></p>
<p class="rvps6" style="clear: both;"><span class="rvts15">Created with the Personal Edition of HelpNDoc: </span><a class="rvts16" href="https://www.helpndoc.com/help-authoring-tool">Full-featured multi-format Help generator</a></p>

            </div>
            
            
        </div>  <!-- /#topic-content -->
    </article>

    <footer></footer>

  </div>  <!-- /#main -->

  <div class="mask" data-toggle="sm-nav-expanded"></div>
  
  <!-- Modal -->
  <div class="modal fade" id="hndModal" tabindex="-1" role="dialog" aria-labelledby="hndModalLabel">
    <div class="modal-dialog" role="document">
      <div class="modal-content">
        <div class="modal-header">
          <button type="button" class="close" data-dismiss="modal" aria-label="Close"><span aria-hidden="true">&times;</span></button>
          <h4 class="modal-title" id="hndModalLabel"></h4>
        </div>
        <div class="modal-body">
        </div>
        <div class="modal-footer">
          <button type="button" class="btn btn-primary modal-btn-close" data-dismiss="modal">Close</button>
        </div>
      </div>
    </div>
  </div>

  <!-- Splitter -->
  <div id="hnd-splitter" style="left: 350px"></div>  

  <!-- Scripts -->
  <script src="vendors/jquery-3.5.1/jquery.min.js"></script>
  <script src="vendors/bootstrap-3.4.1/js/bootstrap.min.js"></script>
  <script src="vendors/bootstrap-3.4.1/js/ie10-viewport-bug-workaround.js"></script>
  <script src="vendors/markjs-8.11.1/jquery.mark.min.js"></script>
  <script src="vendors/uri-1.19.2/uri.min.js"></script>
  <script src="vendors/imageMapResizer-1.0.10/imageMapResizer.min.js"></script>
  <script src="vendors/headroom-0.11.0/headroom.min.js"></script>
  <script src="vendors/jstree-3.3.10/jstree.min.js"></script>  
  <script src="vendors/interactjs-1.9.22/interact.min.js"></script>  

  <!-- HelpNDoc scripts -->
  <script src="js/polyfill.object.min.js"></script>
  <script src="_translations.js"></script>
  <script src="js/hndsd.min.js"></script>
  <script src="js/hndse.min.js"></script>
  <script src="js/app.min.js"></script>

  <!-- Init script -->
  <script>
    $(function() {
      // Create the app
      var app = new Hnd.App({
        searchEngineMinChars: 3
      });
      // Update translations
      hnd_ut(app);
	  // Instanciate imageMapResizer
	  imageMapResize();
	  // Custom JS
	  
      // Boot the app
      app.Boot();
    });
  </script>



</body>

</html>

